Pyxis Oncology, Inc.·4

Sep 8, 5:00 PM ET

Sullivan Lara 4

4 · Pyxis Oncology, Inc. · Filed Sep 8, 2023

Insider Transaction Report

Form 4
Period: 2023-09-07
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
  • Award

    Common Stock

    2023-09-07+469,4832,625,182 total
Footnotes (1)
  • [F1]Represents restricted stock units that are fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION